|
GB9801392D0
(en)
*
|
1998-01-22 |
1998-03-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
WO2000006083A2
(en)
*
|
1998-07-31 |
2000-02-10 |
Eli Lilly And Company |
Sulfonamide derivatives
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US6586592B2
(en)
|
2000-06-20 |
2003-07-01 |
Pharmacia & Upjohn Company |
Bis-arylsulfones
|
|
PE20020063A1
(es)
|
2000-06-20 |
2002-01-30 |
Upjohn Co |
Bis-arilsulfonas como ligandos del receptor de 5-ht
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
US6399617B1
(en)
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
GB0021450D0
(en)
*
|
2000-08-31 |
2000-10-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
JP2004517826A
(ja)
|
2000-11-21 |
2004-06-17 |
スミスクライン ビーチャム パブリック リミテッド カンパニー |
Ｃｎｓ障害の治療において有用なイソキノリン誘導体
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
JP4597480B2
(ja)
|
2001-05-11 |
2010-12-15 |
プロキシマゲン・リミテッド |
肥満、ｉｉ型糖尿病およびｃｎｓ疾患の処置のための新規アリールスルホンアミド化合物
|
|
CA2445653A1
(en)
|
2001-06-11 |
2002-12-19 |
Biovitrum Ab |
Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
|
|
JP4187650B2
(ja)
*
|
2001-08-10 |
2008-11-26 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６レセプター親和性を有するアリールスルホニル誘導体
|
|
AU2007205749B2
(en)
*
|
2001-11-22 |
2009-04-23 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
CA2466490C
(en)
*
|
2001-11-22 |
2009-12-29 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
PL370447A1
(en)
*
|
2001-11-22 |
2005-05-30 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
US7074788B2
(en)
|
2001-11-22 |
2006-07-11 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
RS44304A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
EP1495004A2
(en)
*
|
2002-02-13 |
2005-01-12 |
Glaxo Group Limited |
Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands
|
|
DE60304695T2
(de)
*
|
2002-02-13 |
2006-09-21 |
Glaxo Group Ltd., Greenford |
7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepin-derivate mit 5-hat-6-rezeptor affinität zur behandlung von erkrankungen des zentralnervensystems
|
|
CN1630642A
(zh)
*
|
2002-02-13 |
2005-06-22 |
葛兰素集团有限公司 |
苯磺酰胺衍生物
|
|
GB0204720D0
(en)
*
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Novel use
|
|
ATE398108T1
(de)
*
|
2002-03-27 |
2008-07-15 |
Glaxo Group Ltd |
Chinolinderivate und deren verwendung als 5-ht6 liganden
|
|
NZ536230A
(en)
|
2002-05-13 |
2007-05-31 |
Hoffmann La Roche |
Benzoxazine derivatives as 5-hydroxytryptamine-6 (5-HT6) modulatory neurotransmitter in the brain
|
|
NZ566263A
(en)
*
|
2002-05-24 |
2009-09-25 |
Millennium Pharm Inc |
CCR9 inhibitors and methods of use thereof
|
|
US7943639B2
(en)
|
2002-06-20 |
2011-05-17 |
Proximagen Limited |
Compounds
|
|
EP1897876A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
ATE344030T1
(de)
|
2002-10-18 |
2006-11-15 |
Hoffmann La Roche |
4-piperazinylbenzolsulfonyl-indole mit 5-ht6 rezeptor-affinität
|
|
ATE363470T1
(de)
|
2002-11-18 |
2007-06-15 |
Chemocentryx Inc |
Arylsulfonamide
|
|
US7420055B2
(en)
*
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
*
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
US20070021466A1
(en)
*
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
|
KR100751604B1
(ko)
*
|
2003-03-03 |
2007-08-22 |
에프. 호프만-라 로슈 아게 |
5-ｈｔ6 조절자로서 사용되는 2,5- 및 2,6-치환된테트라하이드로아이소퀴놀린
|
|
TWI289141B
(en)
*
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
GB0305575D0
(en)
*
|
2003-03-11 |
2003-04-16 |
Glaxo Group Ltd |
Novel compounds
|
|
HRP20060100T3
(en)
|
2003-07-22 |
2007-03-31 |
Arena Pharmaceuticals Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
US20050201965A1
(en)
*
|
2004-03-11 |
2005-09-15 |
The Procter & Gamble Company |
Personal cleansing compositions
|
|
WO2005113513A2
(en)
*
|
2004-05-12 |
2005-12-01 |
Chemocentryx |
Aryl sulfonamides
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
DE602005026543D1
(de)
|
2004-09-30 |
2011-04-07 |
Hoffmann La Roche |
Zusammensetzungen und verfahren zur behandlung kognitiver störungen
|
|
EP1695971A1
(en)
*
|
2004-12-30 |
2006-08-30 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted phenyl-piperazine compounds, their preparation and use in medicaments
|
|
AR054044A1
(es)
*
|
2005-05-23 |
2007-05-30 |
Astrazeneca Ab |
Derivados de cromano y tetrahidronaftaleno como moduladores del receptor 5 - ht6; intermediarios en su preparacion; composiciones farmaceuticas que los contienen y su empelo en la fabricacion de medicamentos para el tratamiento de enfermedades del snc y de la obesidad.
|
|
AR054363A1
(es)
*
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
|
BRPI0520579B8
(pt)
*
|
2005-08-12 |
2021-05-25 |
Suven Life Sciences Ltd |
composto, processo para a preparação de um composto e composição farmacêutica
|
|
KR101250820B1
(ko)
|
2005-08-16 |
2013-04-04 |
수벤 라이프 사이언시스 리미티드 |
개선된 로사르탄 제조 방법
|
|
WO2007075895A2
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
WO2007133580A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Zelos Therapeutics, Inc. |
Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
|
|
ES2357584T3
(es)
|
2007-01-08 |
2011-04-27 |
Suven Life Sciences Limited |
Compuestos de 5-(heterociclil) alquil-n-(arilsulfonil)indol y su uso como ligandos de 5-th6.
|
|
ES2389958T3
(es)
*
|
2007-03-21 |
2012-11-05 |
Glaxo Group Limited |
Uso de derivados de quinolina en el tratamiento del dolor
|
|
AR065948A1
(es)
|
2007-04-06 |
2009-07-15 |
Neurocrine Biosciences Inc |
Antagonistas del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
|
|
CL2008000986A1
(es)
|
2007-04-06 |
2008-10-17 |
Neurocrine Biosciences Inc |
COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
|
|
ES2366496T3
(es)
|
2007-05-03 |
2011-10-20 |
Suven Life Sciences Limited |
Compuestos de aminoalcoxi arilsulfonamida y su uso como ligandos 5-ht6.
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
CA2703157C
(en)
|
2007-10-26 |
2013-02-05 |
Suven Life Sciences Limited |
Amino arylsulfonamide compounds and their use as 5-ht6 ligands
|
|
US9084742B2
(en)
|
2007-12-12 |
2015-07-21 |
Axovant Sciences Ltd. |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
|
|
EP2103596A1
(en)
|
2008-03-18 |
2009-09-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
DE102008022221A1
(de)
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
BRPI0913736A2
(pt)
|
2008-09-17 |
2023-04-11 |
Suven Life Sciences Ltd |
Composto, processo para a preparação do composto, composição farmacêutica e método para o tratamento de uma desordem do sistema nervoso central
|
|
WO2010062321A1
(en)
|
2008-10-28 |
2010-06-03 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
|
|
UA100192C2
(en)
*
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
US8362010B2
(en)
|
2009-04-30 |
2013-01-29 |
Abbott Gmbh & Co. Kg |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
MX2011011519A
(es)
|
2009-04-30 |
2012-01-30 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonanilida adecuados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
CN102459197B
(zh)
*
|
2009-04-30 |
2015-08-19 |
Abbvie公司 |
适用于治疗响应血清素5-ht6受体的调节的病症的n-苯基-(哌嗪基或高哌嗪基)-苯磺酰胺或苯磺酰基-苯基-(哌嗪或高哌嗪)化合物
|
|
US20120225862A1
(en)
*
|
2009-07-21 |
2012-09-06 |
Auckland Univservices Limited |
Heteroaryl benzamides, compositions and methods of use
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
CA2786072C
(en)
|
2010-01-05 |
2014-10-28 |
Suven Life Sciences Limited |
Sulfone compounds as 5-ht6 receptor ligands
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2012059432A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
US9708276B2
(en)
|
2011-10-12 |
2017-07-18 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
|
|
PE20142400A1
(es)
*
|
2012-04-27 |
2015-02-04 |
Glaxo Group Ltd |
Compuestos novedosos
|
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
US10882834B2
(en)
|
2013-09-20 |
2021-01-05 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Compounds for treating prostate cancer
|
|
CN104557664B
(zh)
*
|
2013-10-19 |
2020-01-21 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
|
CA2928537A1
(en)
*
|
2013-10-25 |
2015-04-30 |
Glaxosmithkline Llc |
Novel compounds
|
|
US9663498B2
(en)
|
2013-12-20 |
2017-05-30 |
Sunshine Lake Pharma Co., Ltd. |
Aromatic heterocyclic compounds and their application in pharmaceuticals
|
|
US9840482B2
(en)
|
2014-04-19 |
2017-12-12 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
CN105367474A
(zh)
*
|
2014-08-12 |
2016-03-02 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN104496987B
(zh)
*
|
2014-12-12 |
2016-03-02 |
广东东阳光药业有限公司 |
取代杂环类化合物及其在药物上的应用
|
|
CN104529866A
(zh)
*
|
2014-12-12 |
2015-04-22 |
广东东阳光药业有限公司 |
吲哚类衍生物及其在药物上的应用
|
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
|
WO2017011767A2
(en)
|
2015-07-15 |
2017-01-19 |
Axovant Sciences Ltd. |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
|
|
HK1257102A1
(zh)
|
2015-08-21 |
2019-10-11 |
Portola Pharmaceuticals, Inc. |
苯基哌嗪前蛋白转化酶枯草杆菌蛋白酶/kexin9型(pcsk9)调节剂及其应用
|
|
WO2017034994A1
(en)
|
2015-08-21 |
2017-03-02 |
Portola Pharmaceuticals, Inc. |
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activity
|
|
HK1260897A1
(zh)
|
2015-08-21 |
2019-12-27 |
Portola Pharmaceuticals, Inc. |
使用四氢异喹啉小分子来结合并调节pcsk9的蛋白活性的组合物和方法
|
|
US20190119236A1
(en)
|
2016-02-23 |
2019-04-25 |
Portola Pharmaceuticals, Inc. |
Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
US10980806B2
(en)
|
2016-03-24 |
2021-04-20 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN111517963A
(zh)
*
|
2020-06-02 |
2020-08-11 |
杭州福莱蒽特科技有限公司 |
环保型2，6-二氯-4-硝基苯胺的制备方法
|
|
US12115154B2
(en)
|
2020-12-16 |
2024-10-15 |
Srx Cardio, Llc |
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
|